News Focus
News Focus
icon url

gfp927z

10/16/07 2:42 PM

#11445 RE: Market_Fest4 #11440

MarketFest, Yes, a BP would be better all around. The high impacts would finally get full funding, and a bunch of new compounds could enter the clinic targeting numerous indications. Ampakine's promise could finally be fulfilled.